NCT02177357View on ClinicalTrials.gov

Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 1998

Primary Completion Date

January 31, 2000

Conditions
Parkinson Disease
Interventions
DRUG

Pramipexole

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY